Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis

Published:2020-10-17 Issue:3 Volume:77 Page:321-329
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Bœuf-Gibot Sylvaine,Pereira Bruno,Imbert Jérémy,Kerroum Hanna,Menini Thibault,Lafarge Elodie,De Carvalho Manuela,Vorilhon Philippe,Boussageon Rémy,Vaillant-Roussel Hélène^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-020-03018-4.pdf

Reference27 articles.

1. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG, American Heart Association Advocacy Coordinating Committee, Council on Arteriosclerosis, Thrombosis and Vascular Biology., Council on Cardiovascular Radiology and Intervention., Council on Clinical Cardiology., Council on Epidemiology and Prevention., Stroke Council (2013) Forecasting the impact of heart failure in the United States : a policy statement from the American Heart Association. Circ Heart Fail 6(3):606–619

2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200

3. Hoffmann TC, Montori VM, Del Mar C (2014) The connection between evidence-based medicine and shared decision making. JAMA 312(13):1295–1296

4. Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273:1450–1456

5. Xie W, Zheng F, Song X, Zhong B, Yan L (2016) Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: network meta-analysis. Int J Cardiol 205:65–71

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro inhibitor effect and molecular docking of thiamine (vitamin B ₁ ), riboflavin (vitamin B ₂ ), and reference inhibitor captopril on angiotensin-converting enzyme purified from sheep plasma;Archives of Physiology and Biochemistry;2024-07-10

2. Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis;PLOS ONE;2023-12-04

3. The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPK;Journal of Pharmaceutical Analysis;2023-09

4. Polypharmacy and risk of mortality among patients with heart failure following hospitalization: a nested case–control study;Scientific Reports;2022-11-19

5. Iron Deposition and Ferroptosis in the Spleen in a Murine Model of Acute Radiation Syndrome;International Journal of Molecular Sciences;2022-09-20